Moderna Releases Details Of New Vaccine Deals While Novavax Moves To Phase 3

Both companies stand to earn billions as their coronavirus vaccine programs move forward.

Read the full post on Forbes - Healthcare

Leah Rosenbaum, Forbes Staff